Brief: Everest Medicines And Providence Therapeutics Announces That PTX-COVID19-B, A MRNA Vaccine For COVID-19 Has Received Approval For Inclusion In WHO Solidarity Trial Vaccines (STV) Program
20/12/2021 13:16
Dec 20 (Reuters) - Everest Medicines Ltd 1952.HK :
* EVEREST MEDICINES AND PROVIDENCE THERAPEUTICS ANNOUNCES
THAT
PTX-COVID19-B, A MRNA VACCINE FOR COVID-19, HAS RECEIVED
APPROVAL FOR INCLUSION IN WHO SOLIDARITY TRIAL VACCINES (STV)
PROGRAM
Source text for Eikon: ID:nPnbbK40na
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region